Your browser doesn't support javascript.
loading
Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies.
Ahn, Myung-Ju; Tsai, Chun-Ming; Shepherd, Frances A; Bazhenova, Lyudmila; Sequist, Lecia V; Hida, Toyoaki; Yang, James C H; Ramalingam, Suresh S; Mitsudomi, Tetsuya; Jänne, Pasi A; Mann, Helen; Cantarini, Mireille; Goss, Glenwood.
Afiliação
  • Ahn MJ; Section of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Tsai CM; Department of Oncology, Taipei-Veterans General Hospital and School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Shepherd FA; Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, Ontario, Canada.
  • Bazhenova L; Department of Medicine, University of California-San Diego, Moores Cancer Center, La Jolla, California.
  • Sequist LV; Department of Hematology Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Hida T; Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Yang JCH; Department of Oncology, National Taiwan University Hospital, National Taiwan University Cancer Center, Taipei City, Taiwan.
  • Ramalingam SS; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.
  • Mitsudomi T; Department of Thoracic Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
  • Jänne PA; Lowe Center for Thoracic Oncology, The Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Mann H; Biometrics and Information Science, AstraZeneca, Cambridge, United Kingdom.
  • Cantarini M; Global Medicines Development, AstraZeneca, Alderley Park, United Kingdom.
  • Goss G; Division of Medical Oncology, The Ottawa Hospital Cancer Center, University of Ottawa, Ottawa, Ontario, Canada.
Cancer ; 125(6): 892-901, 2019 03 15.
Article em En | MEDLINE | ID: mdl-30512189
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Acrilamidas / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Compostos de Anilina / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Acrilamidas / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Compostos de Anilina / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article